题名 | Interim safety results from the East/South East (E/SE) Asian subgroup of the open-label TRUST (TaRceva lUng cancer Survival Treatment) study of erlotinib for advanced non-small-cell lung cancer (NSCLC): PD3-2-6 |
链接 | http://journals.lww.com/jto/Citation/2007/08001/Interim_safety_results_from_the_East_South_East.494.aspx |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |